TITLE

Evaluating the Clinical Accuracy of Two Continuous Glucose Sensors Using Continuous Glucose-Error Grid Analysis

AUTHOR(S)
Clarke, William L.; Anderson, Stacey; Farhy, Leon; Breton, Marc; Gonder-Frederick, Linda; Cox, Daniel; Kovatchev, Boris
PUB. DATE
October 2005
SOURCE
Diabetes Care;Oct2005, Vol. 28 Issue 10, p2412
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE -- To compare the clinical accuracy of two different continuous glucose sensors (CGS) during euglycemia and hypoglycemia using continuous glucose-error grid analysis (CG-EGA). RESEARCH DESIGN AND METHODS -- FreeStyle Navigator (Abbott Laboratories, Alameda, CA) and MiniMed CGMS (Medtronic, Northridge, CA) CGSs were applied to the abdomens of 16 type 1 diabetic subjects (age 42 ± 3 years) 12 h before the initiation of the study. Each system was calibrated according to the manufacturer's recommendations. Each subject underwent a hyperinsulinemic-euglycemic clamp (blood glucose goal 110 mg/dl) for 70-210 min followed by a 1 - mg ⋅ dl-1 ⋅ min-1 controlled reduction in blood glucose toward a nadir of 40 mg/dl. Arterialized blood glucose was determined every 5 min using a Beckman Glucose Analyzer (Fullerton, CA). CGS glucose recordings were matched to the reference blood glucose with 30-s precision, and rates of glucose change were calculated for 5-min intervals. CG-EGA was used to quantify the clinical accuracy of both systems by estimating combined point and rate accuracy of each system in the euglycemic (70-180 mg/dl) and hypoglycemic (<70 mg/dl) ranges. RESULTS -- A total of 1,104 data pairs were recorded in the euglycemic range and 250 data pairs in the hypoglycemic range. Overall correlation between CGS and reference glucose was similar for both systems (Navigator, r -- 0.84; CGMS, r = 0.79, NS). During euglycemia, both CGS systems had similar clinical accuracy (Navigator zones A + B, 88.8%; CGMS zones A + B, 89.3%, NS). However, during hypoglycemia, the Navigator was significantly more clinically accurate than the CGMS (zones A + B - 82.4 vs. 61.6%, Navigator and CGMS, respectively, P < 0.0005). CONCLUSIONS -- CG-EGA is a helpful tool for evaluating and comparing the clinical accuracy of CGS systems in different blood glucose ranges. CG-EGA provides accuracy details beyond other methods of evaluation, including correlational analysis and the original EGA.
ACCESSION #
18549089

 

Related Articles

  • Implantable, Continuous Sensor Reduced Glucose Fluctuations in Type 1 Diabetes.  // Ascribe Newswire: Medicine;3/4/2004, p9 

    Adults with type 1 diabetes experienced decreased periods of high or low blood sugar when using a long-term implantable, continuous glucose sensor, according to a study in the March issue of the journal Diabetes Care. Researchers at the University of Colorado Health Sciences Center's Barbara...

  • Central Versus Peripheral Glucose Sensing and the Response to Hypoglycemia. Cherrington, Alan D. // Diabetes;May2008, Vol. 57 Issue 5, p1158 

    The author expresses views on a study on central versus peripheral glucose sensing of hypoglycemia. He cites that the occurrence of hypoglycemia is one of the most important limits in the ability of an individual to control blood glucose in diabetics. He says the research found out that the rate...

  • Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Ryan, Edmond A.; Shandro, Tami; Green, Kristy; Paty, Breay W.; Senior, Peter A.; Bigam, David; Shapiro, A. M. James; Vantyghem, Marie-Christine // Diabetes;Apr2004, Vol. 53 Issue 4, p955 

    Currently, the major indications for solitary islet transplantation are recurrent severe hypoglycemia and labile glucose control. Quantifying these problems remains subjective. We have developed a scoring system for both hypoglycemia and glycemic lability, established normative data, and used...

  • Development of diabetes after gatifloxacin therapy. Stading, Julie A.; Chock, Alan W. Y.; Skrabal, Maryann Z.; Faulkner, Michele A. // American Journal of Health-System Pharmacy;11/1/2005, Vol. 62 Issue 21, p2293 

    Focuses on the development of diabetes after gatifloxacin therapy. Disturbances of blood glucose; Inclusion of symptomatic hyper- and hypoglycemia; Increase in serum insulin levels; Determination of patient's blood glucose concentration.

  • Take Care During Basal Insulin Transition. Karl, Elka // Diabetes Health;Oct2004, Vol. 13 Issue 10, p18 

    Presents a caution by researchers to children with type 1 diabetes who switched to Lantus due to nighttime hypoglycemia. Decrease in night time blood glucose being experienced by type 1 diabetics who switched to Lantus; Occurrence of seizures related to low blood glucose in patients.

  • Mechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes. Cryer, Philip E. // Diabetes;Dec2005, Vol. 54 Issue 12, p3592 

    Iatrogenic hypoglycemia is a problem for people with diabetes. It causes recurrent morbidity, and sometimes death, as well as a vicious cycle of recurrent hypoglycemia, precluding maintenance of euglycemia over a lifetime of diabetes. Improved therapeutic approaches that will minimize both hypo-...

  • Effect of Automated Bio-Behavioral Feedback on the Control of Type 1 Diabetes. KOVATCHEV, BORIS P.; MENDOSA, PAMELA; Anderson, Stacey; HAWLEY, JEFFREY S.; RITTERBAND, LEE M.; GONDER-FREDERICK, LINDA // Diabetes Care;Feb2011, Vol. 34 Issue 2, p302 

    OBJECTIVE-To test the effect of an automated system providing real-time estimates of HbA1c, glucose variability, and risk for hypoglycemia. RESEARCH DESIGN AND METHODS--For 1 year, 120 adults with type 1 diabetes (69 female/51 male, age = 39.1 [14.3] years, duration of diabetes 20.3 [12.9]...

  • Evaluation of daily glycemic profiles in well controlled children with type 1 diabetes mellitus using a continuous glucose monitoring system. Tucholski, Krzysztof; Deja, Grażyna; Skała-Zamorowska, Eliza; Jarosz-Chobot, Przemysława // Pediatric Endocrinology, Diabetes & Metabolism;2009, Vol. 15 Issue 1, p29 

    Introduction: Effective diabetes mellitus management requires to maintain blood glucose levels in a narrow range between hyperglycemia causing late complications, and danger of severe hypoglycemia. This objective may be difficult to achieve especially in small children. The aim of the study:...

  • Continuous Glucose Monitoring of Cyclists with Type 1 Diabetes: Team Type I in the Race Across America. Bode, Molly; Olson, Darin E.; Demma, Linda; Sax, Jill; Bode, Bruce // Diabetes;Jun2007 Supplement 1, Vol. 56, pA109 

    This study was conducted to determine the efficacy and utility of the Freestyle Navigator Continuous Glucose Monitoring system (CGMS) during intense exercise. Eight cyclists with type 1 diabetes used the CGMS in a blinded phase while preparing for the Race Across America (RAAM), followed by an...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics